Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma
Clinical trial NCT01404702 · TERMINATED
Trial details
- NCT number
- NCT01404702
- Sponsor
- University of Alabama at Birmingham
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2014-08-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.